XML 24 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Share Capital (Tables)
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s option activity related to options to employees and directors, and related information is as follows:

 

   For the Nine months ended September 30, 2019 
  

Number of

stock options

   Weighted average exercise price   Aggregate intrinsic value 
             
Outstanding at beginning of period   398,308   $11.50   $108 
Granted   29,133    7.00    - 
Exercised   -    -    - 
Cancelled   -    -    - 
Outstanding at end of period   427,441   $11.15   $417 
                
Vested at end of period   306,723   $9.90   $417 

 

   For the Year ended December 31, 2018 
  

Number of

stock options

   Weighted average exercise price   Aggregate intrinsic value 
             
Outstanding at beginning of period   414,965   $11.70   $1,859 
Granted   10,000    9.00    - 
Exercised   (2,487)   -    - 
Cancelled   (24,170)   -    - 
Outstanding at end of period   398,308   $11.50   $108 
                
Vested at end of period   245,010   $8.45   $108 

 

Schedule of Stock Options Outstanding

The stock options outstanding as of September 30, 2019 and December 31, 2018, summarized by exercise prices, are as follows:

 

Exercise price $   Stock options outstanding as of September 30, 2019   Stock options outstanding as of December 31, 2018   Weighted average remaining contractual life – years as of September 30, 2019   Weighted average remaining contractual life – years as of December 31, 2018   Stock options exercisable as of September 30, 2019   Stock options exercisable as of December 31, 2018 
                          
 4.20    77,846    77,846    6.3    7.0    77,846    77,846 
 15.75    133,546    133,546    8.0    8.8    83,005    53,752 
 8.60    11,630    -    9.3    -    4,645    - 
 9.00    10,000    10,000    9.0    9.8    4,000    - 
 19.35    72,508    72,508    8.0    8.8    45,318    29,003 
 5.95    17,503    -    2.8    -    -    - 
 15.30    41,866    41,866    8.3    9.0    29,367    21,867 
 (*)   62,542    62,542    7.0    7.8    62,542    62,542 
      427,441    398,308    6.3    7.3    306,723    245,010 

 

 

(*) Less than $0.01.

Schedule of Stock Options Valuation Assumptions

The fair value of the stock options is estimated at the date of grant using the Black-Scholes options pricing model with the following weighted-average assumptions:

 

    Nine Months ended
September 30, 2019
    Year ended
December 31, 2018
 
             
Expected volatility     133.43%-144.4 %     99.40 %
Risk-free interest     1.64 %     2.39 %
Dividend yield     0 %     0 %
Expected life of up to (years)     6.37-6.73       5.24  

Schedule of Warrants Outstanding

The remaining outstanding warrants and terms as of September 30, 2019 and December 31, 2018 are as follows:

 

Issuance date   Outstanding as of December 31, 2018     Outstanding as of September 30, 2019     Exercise Price     Exercisable as of September 30, 2019     Exercisable Through
                             
Series A (2013)     181       181     $ 2,754.00       181     April 9, 2023
Series A (2015)     676       676     $ 1,377.00       676     April 30, 2020
Series B (2016) (a)     2,741       2,741     $ 40.50       2,741     March 14, 2022